5:53 PM
 | 
Jul 12, 2012
 |  BC Extra  |  Financial News

Ampio planning follow-on

Ampio Pharmaceuticals Inc. (NASDAQ:AMPE) said late Thursday it is planning a follow-on underwritten...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >